Literature DB >> 454563

Histological grade and other prognostic factors in relation to survival of patients with breast cancer.

L S Freedman, D N Edwards, E M McConnell, D Y Downham.   

Abstract

Records of 3085 patients registered with breast cancer at the Mersey Regional Cancer Registry have been analysed to evaluate the relative importance of possible prognostic factors. In a subgroup of 1759 patients, clinical stage and histological grade are shown to be strongly related to survival after treatment. In addition histological grade is related to the distribution of times to death after treatment. The results of this and 3 other studies have implications for the design and analysis of clinical trials in the primary treatment of breast cancer.

Entities:  

Mesh：

Year:  1979        PMID： 454563      PMCID： PMC2009958          DOI： 10.1038/bjc.1979.139

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


  9 in total

1.  On the use of indicator variables for studying the time-dependence of parameters in a response-time model.

Authors:  C C Brown
Journal:  Biometrics       Date:  1975-12       Impact factor: 2.571

2.  Relationship of pathologic and some clinical discriminants to the spread of breast cancer.

Authors:  E R Fisher; B Fisher
Journal:  Int J Radiat Oncol Biol Phys       Date:  1977 Jul-Aug       Impact factor: 7.038

Review 3.  Statistical methods for the identification and use of prognostic factors.

Authors:  P Armitage; E A Gehan
Journal:  Int J Cancer       Date:  1974-01-15       Impact factor: 7.396

4.  1-Phenylalanine mustard (L-PAM) in the management of primary breast cancer. A report of early findings.

Authors:  B Fisher; P Carbone; S G Economou; R Frelick; A Glass; H Lerner; C Redmond; M Zelen; P Band; D L Katrych; N Wolmark; E R Fisher
Journal:  N Engl J Med       Date:  1975-01-16       Impact factor: 91.245

5.  The pattern of spread and survival in 596 cases of breast cancer related to clinical staging and histological grade.

Authors:  J S Bunting; E H Hemsted; J K Kremer
Journal:  Clin Radiol       Date:  1976-01       Impact factor: 2.350

6.  Combination chemotherapy as an adjuvant treatment in operable breast cancer.

Authors:  G Bonadonna; E Brusamolino; P Valagussa; A Rossi; L Brugnatelli; C Brambilla; M De Lena; G Tancini; E Bajetta; R Musumeci; U Veronesi
Journal:  N Engl J Med       Date:  1976-02-19       Impact factor: 91.245

7.  Prognostic typing in breast cancer.

Authors:  F Hartveit
Journal:  Br Med J       Date:  1971-10-30

8.  Prognosis in carcinoma of the breast.

Authors:  H J G BLOOM
Journal:  Br J Cancer       Date:  1950-09       Impact factor: 7.640

9.  Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years.

Authors:  H J BLOOM; W W RICHARDSON
Journal:  Br J Cancer       Date:  1957-09       Impact factor: 7.640
  9 in total
  19 in total

1.  Prognostic factors in node-positive operable breast cancer patients receiving adjuvant chemotherapy.

Authors:  E Rakowsky; B Klein; E Kahan; E Derazne; H Lurie
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

2.  Progesterone binding cyst protein (PBCP) in primary breast cancer: a new prognostic factor?

Authors:  J A Søreide; O A Lea; S Kvinnsland
Journal:  Breast Cancer Res Treat       Date:  1987       Impact factor: 4.872

3.  Markers of prognosis in breast cancer--the relationship between binding of the lectin HPA and histological grade, SPF, and ploidy.

Authors:  S A Brooks; A J Leathem; R S Camplejohn; W Gregory
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

4.  Oestrogen and progesterone receptor content and the distribution of histological grade in breast cancer.

Authors:  S Thoresen; T Thorsen; M Tangen; F Hartveit
Journal:  Breast Cancer Res Treat       Date:  1982       Impact factor: 4.872

5.  Improved prognostication in small (pT1) breast cancers by image cytometry.

Authors:  M Aubele; G Auer; U Falkmer; A Voss; K Rodenacker; L E Rutquist; H Höfler
Journal:  Breast Cancer Res Treat       Date:  1995       Impact factor: 4.872

6.  Monoclonal antibody DF3 correlates with tumor differentiation and hormone receptor status in breast cancer patients.

Authors:  J Lundy; A Thor; R Maenza; J Schlom; F Forouhar; M Testa; D Kufe
Journal:  Breast Cancer Res Treat       Date:  1985       Impact factor: 4.872

7.  New criteria to predict tumor recurrence in invasive ductal carcinoma of the breast.

Authors:  Tadahiro Nozoe; Emiko Mori; Tomohiro Iguchi; Takahiro Ezaki
Journal:  Int Surg       Date:  2013 Oct-Dec

8.  Lacking prognostic significance of beta 2-microglobulin, MHC class I and class II antigen expression in breast carcinomas.

Authors:  H O Wintzer; M Benzing; S von Kleist
Journal:  Br J Cancer       Date:  1990-08       Impact factor: 7.640

9.  Survival of breast cancer patients diagnosed during pregnancy or lactation.

Authors:  S Tretli; G Kvalheim; S Thoresen; H Høst
Journal:  Br J Cancer       Date:  1988-09       Impact factor: 7.640

10.  Prognostic implications of mean nuclear diameter in breast cancer.

Authors:  L J van Bogaert; C de Muylder; P Maldague; H Maisin
Journal:  Br J Cancer       Date:  1980-10       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.